Ameriprise

Ameriprise’s UroGen Pharma URGN Stock Holding History

Ameriprise’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$542K	Sell	30,166 -105,853	-78%	-$2.12M	﹤0.01%	3555
2025 Q4	$3.19M	Buy	136,019 +105,535	+346%	+$2.29M	﹤0.01%	2749
2025 Q3	$608K	Sell	30,484 -396	-1%	-$7.11K	﹤0.01%	3560
2025 Q2	$423K	Sell	30,880 -2,878	-9%	-$27.6K	﹤0.01%	3587
2025 Q1	$373K	Sell	33,758 -15,395	-31%	-$164K	﹤0.01%	3604
2024 Q4	$523K	Buy	49,153 +4,188	+9%	+$50.1K	﹤0.01%	3512
2024 Q3	$571K	Sell	44,965 -110	-0.2%	-$1.63K	﹤0.01%	3437
2024 Q2	$756K	Sell	45,075 -25,877	-36%	-$368K	﹤0.01%	3280
2024 Q1	$1.06M	Sell	70,952 -2,009	-3%	-$32.8K	﹤0.01%	3137
2023 Q4	$1.09M	Sell	72,961 -13,148	-15%	-$171K	﹤0.01%	3146
2023 Q3	$1.21M	Buy	86,109 +1,069	+1%	+$17.2K	﹤0.01%	3057
2023 Q2	$880K	Buy	85,040 +4,033	+5%	+$44.5K	﹤0.01%	3227
2023 Q1	$749K	Hold	81,007	–	–	﹤0.01%	3276
2022 Q4	$718K	Sell	81,007 -1,042	-1%	-$9.87K	﹤0.01%	3270
2022 Q3	$682K	Buy	+82,049	New	+$679K	﹤0.01%	3280

Other funds holding URGN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

SG Americas Securities

SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return

American Century Companies

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return